Polyphenol (-)-epigallocatechin gallate-induced cardioprotection may attenuate ischemia-reperfusion injury through adenosine receptor activation: A preliminary study

Korean Journal of Anesthesiology

Volumn 63, Issue 4, 2012, Pages 340-345

  Lee, Sang Kwon ^a   Kim, June Hong ^a   Kim, Jeong Su ^a   Jang, Youngho ^a   Kim, Jun ^a   Park, Yong Hyun ^a   Chun, Kook Jin ^a   Lee, Mi Young ^b  

^a Pusan National University Yangsan Hospital   (South Korea)

^b Keimyung University School of Medicine   (South Korea)

Author keywords

Adenosine; Epigallocatechin gallate; Myocardial infarction; Reperfusion injury

Indexed keywords

4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; 8 (4 SULFOPHENYL)THEOPHYLLINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2B RECEPTOR; ADENOSINE RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; EPIGALLOCATECHIN GALLATE; MRS 1334; MRS 1706; NALOXONE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG MECHANISM; HEART INFARCTION SIZE; HEART PROTECTION; ISOLATED HEART; MALE; NONHUMAN; RAT; REPERFUSION INJURY;

EID: 84868306555     PISSN: 20056419     EISSN: 20057563     Source Type: Journal    
DOI: 10.4097/kjae.2012.63.4.340     Document Type: Article

References (22)

1. Song DK, Jang Y, Kim JH, Chun KJ, Lee D, Xu Z. Polyphenol (-)-epigallocatechin gallate during ischemia limits infarct size via mitochondrial KATP channel activation in isolated rat hearts. J Korean Med Sci 2010; 25: 380-386.
2. Kim CJ, Kim JM, Lee SR, Jang YH, Kim JH, Chun KJ. Polyphenol (-)- epigallocatechin gallate targeting myocardial reperfusion limits infarct size and improves cardiac function. Korean J Anesthesiol 2010; 58: 169-175.
3. Hansen JL, Theilade J, Aplin M, Sheikh SP. Role of G-protein-coupled receptor kinase 2 in the heart-do regulatory mechanisms open novel therapeutic perspectives? Trends Cardiovasc Med 2006; 16: 169-177.
4. McIntosh VJ, Lasley RD. Adenosine receptor-mediated cardioprotection: are all 4 inftypes required or redundant? J Cardiovasc Pharmacol Ther 2012; 17: 21-33.
5. Chen Z, Li T, Zhang B. Morphine postconditioning protects against reperfusion injury in the isolated rat hearts. J Surg Res 2008; 145: 287-294.
6. Chun KJ, Park YH, Kim JS, Jang Y, Kim JH, Kim J, et al. Comparison of 5 different remifentanil strategies against myocardial ischemia-reperfusion injury. J Cardiothorac Vasc Anesth 2011; 25: 926-30.
7. Strande JL, Hsu A, Su J, Fu X, Gross GJ, Baker JE. Inhibiting protease-activated receptor 4 limits myocardial ischemia/reperfusion injury in rat hearts by unmasking adenosine signaling. J Pharmacol Exp Ther 2008; 324: 1045-1054.
8. Ebrahimi S, Faghihi M, Keshavarz M, Kadkhodaee M, Mirershadi F, Asadi B. Anti-infarct effect of magnesium is not mediated by adenosine A1 receptors in rat globally ischaemic isolated hearts. Clin Exp Pharmacol Physiol 2004; 31: 868-872.
9. Xi J, McIntosh R, Shen X, Lee S, Chanoit G, Criswell H, et al. Adenosine A2A and A2B receptors work in concert to induce a strong protection against reperfusion injury in rat hearts. J Mol Cell Cardiol 2009; 47: 684-690.
10. Monahan TS, Sawmiller DR, Fenton RA, Dobson JG Jr. Adenosine A(2a)-receptor activation increases contractility in isolated perfused hearts. Am J Physiol Heart Circ Physiol 2000; 279: H1472-H1481.
11. Park SS, Zhao H, Jang Y, Mueller RA, Xu Z. N6-(3-iodobenzyl)-adenosine-5'-N-methylcarboxamide confers cardioprotection at reperfusion by inhibiting mitochondrial permeability transition pore opening via glycogen synthase kinase 3 beta. J Pharmacol Exp Ther 2006; 318: 124-131.
12. Navarro-Perán E, Cabezas-Herrera J, Campo LS, Rodríguez-López JN. Effects of folate cycle disruption by the green tea polyphenol epigallocatechin-3-gallate. Int J Biochem Cell Biol 2007; 39: 2215-2225.
13. Vasara E, Katharou I, Lazou A. Myocardial adenosine does not correlate with the protection mediated by ischaemic or pharmacological preconditioning in rat heart. Clin Exp Pharmacol Physiol 2003; 30: 350-356.
14. Smits GJ, McVey M, Cox BF, Perrone MH, Clark KL. Cardioprotective effects of the novel adenosine A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarction. J Pharmacol Exp Ther 1998; 286: 611-618.
15. Safran N, Shneyvays V, Balas N, Jacobson KA, Nawrath H, Shainberg A. Cardi oprotective effects of adenosine A1 and A3 receptor activation during hypoxia in isolated rat cardiac myocytes. Mol Cell Biochem 2001; 217: 143-152.
16. Maddock HL, Mocanu MM, Yellon DM. Adenosine A(3) receptor activation protects the myocardium from reperfusion/reoxygenation injury. Am J Physiol Heart Circ Physiol 2002; 283: H1307-H1313.
17. Liang BT. Direct preconditioning of cardiac ventricular myocytes via adenosine A1 receptor and KATP channel. Am J Physiol 1996; 271: H1769-H1777.
18. Ballard-Croft C, Kristo G, Yoshimura Y, Reid E, Keith BJ, Mentzer RM Jr, et al. Acute adenosine preconditioning is mediated by p38 MAPK activation in discrete infcellular compartments. Am J Physiol Heart Circ Physiol 2005; 288: H1359-66.
19. Liu GS, Thornton J, Van Winkle DM, Stanley AW, Olsson RA, Downey JM. Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation 1991; 84: 350-356.
20. Auchampach JA, Rizvi A, Qiu Y, Tang XL, Maldonado C, Teschner S, et al. Selective activation of A3 adenosine receptors with N6-(3-iodobenzyl)-adenosine-5-N-methyluronamide protects against myocardial stunning and infarction without hemodynamic changes in conscious rabbits. Circ Res 1997; 80: 800-809.
21. Zhao ZQ, McGee S, Nakanishi K, Toombs CF, Johnston WE, Ashar MS, et al. Receptor-mediated cardioprotective effects of endogenous adenosine are exerted primarily during reperfusion after coronary occlusion in the rabbit. Circulation 1993; 88: 709-719.
22. Philipp S, Yang XM, Cui L, Davis AM, Downey JM, Cohen MV. Postconditioning protects rabbit hearts through a protein kinase C-adenosine A2b receptor cascade. Cardiovasc Res 2006; 70: 308-314.